When are IP holders liable for enforcing a later invalidated IP right?

When are IP holders liable for enforcing a later invalidated IP right?
January 16, 2023 January 30, 2023 13:30


On behalf of our entire IP team, we first and foremost would like to wish you the very best for the New Year, and invite you to our first IP Update of 2023.

At this IP Update, our IP specialists, Christophe Ronse and Kirian Claeyé, will discuss under what circumstances IP holders may be held liable for enforcing a later invalidated IP right.

As many of you will know, this is a ‘hot’ topic. In 2019, the CJEU delivered its judgment in Bayer v Gedeon Richter (C-688/17), which addressed this question regarding the loss suffered from a provisional injunction based on a subsequently invalidated patent. On 11 October 2022, the Brussels Court of Appeal delivered its judgment in Mylan v Novartis applying the CJEU’s principles to a case where the patentee had enforced a provisional injunction based on the Belgian tier of a subsequently invalidated European patent. The day before, on 10 October 2022, the Finnish Markinnaoikeus had referred another question for a preliminary ruling to the CJEU relating to a subsequently invalidated SPC (C-473/22).

Christophe and Kirian will focus on these two judgments and the pending referral in the broader context of earlier case law and explain what their outcomes could mean for your business. They will answer questions that include:

  1. Is an IP holder automatically liable for enforcing a provisional injunction based on a later invalidated IP right?
  2. Is the answer different if it concerns a first instance provisional injunction that is later overturned on appeal?
  3. Under what circumstances would an IP holder be considered to have ‘abused’ its right to enforce the later invalidated right?

This webinar will be in English and has been accredited with 1 point by the IBJ/IJE.

We look forward to virtually meeting you soon!

Your hosts

  • Christophe Ronse

    Partner

  • Kirian Claeyé

    Partner

Recommended articles

September 08, 2026

Screws loose? The CJEU weighs in on a trade mark parody gone political

CJEU’s judgment of 8 September 2026 in Case C-298/23, Inter IKEA Systems BV v Algemeen Vlaams Belang VZW (Reference for a preliminary ruling from the Nederlandstalige Ondernemingsrechtbank Brussel – Brussels Dutch-speaking Business Court, Belgium). 1. Summary of the facts On 14 November 2022, the Belgian far-right political party Vlaams Belang publicly presented, at a press […]

Read on
August 10, 2026

Belgian Pharma Law Summer Blog Series (Part 3): the recently passed ‘Bill containing various provisions on health’

In our Belgian Pharma Law Summer Blog Series, we examine recent developments in Belgian pharmaceutical law. Whether you are looking for an informative summer read or a concise overview of the latest legal developments to catch up on after the holidays, our series has you covered. Our third and final part examines the ‘Bill containing […]

Read on
August 03, 2026

Belgian Pharma Law Summer Blog Series (Part 2): the new ‘Article 10 guidance’ on pharmaceutical promotion

In our Belgian Pharma Law Summer Blog Series, we examine recent developments in Belgian pharmaceutical law. Whether you are looking for an informative summer read or a concise overview of the latest legal developments to catch up on after the holidays, our series has you covered. Part 2 focuses on the new guidance on the […]

Read on